01394nam 2200409 450 991070748500332120160811094856.0(CKB)5470000002464675(OCoLC)956502761(OCoLC)995470000002464675(EXLCZ)99547000000246467520160811d2005 ua 0engurmn|||||||||rdacontentrdamediardacarrierDeficiencies in the oversight of the 340B drug pricing program[Washington, D.C.] :Department of Health and Human Services, Office of Inspector General,2005.1 online resource (v, 37 pages) illustrationTitle from title screen (viewed Aug. 9, 2016)."October 2005.""OEI-05-02-00072."Includes bibliographical references (pages 26-27).Deficiencies in the oversight of the 340B drug pricing programMedicaidAuditingDrugsPricesUnited StatesPharmaceutical policyUnited StatesMedicaidAuditing.DrugsPricesPharmaceutical policyGPOGPOBOOK9910707485003321Deficiencies in the oversight of the 340B drug pricing program3304891UNINA